Salk Institute for Biological Studies

The Novo Nordisk Foundation and the Broad Institute introduced a new Center for Genomic Mechanisms of Disease research unit on 15 September, to be housed at the Harvard University / Massachusetts I

Exo Therapeutics, Inc. launched in December with $25m in series A venture capital and has advanced its ExoSight technology platform far enough since then to justify a $78m series B round that the com

By the end of the year, Metacrine, Inc. plans to select which of its two farnesoid X receptor (FXR) agonists in mid-stage development to move forward with in non-alcoholic steatohepatitis (NASH), an

The week before the annual J.P. Morgan Healthcare Conference always includes a bevy of new financings and the week before this year’s 11-14 January meeting kept up with the tradition with $1.67bn in v